Gilead Sciences INC GILEAD SCIENCES ORD SHS
Gilead Sciences INC GILEAD SCIENC.../ US3755581036 /
0QYQ
2024-05-24 6:04:40 PM
|
Chg.
-0.83
|
Volume |
Bid6:30:00 PM |
Ask6:30:00 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
66.42USD
|
-1.23%
|
6,526 Turnover: 96,741.02 |
-Bid Size: - |
-Ask Size: - |
81.83 bill.USD |
4.57% |
14.47 |
Business description
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Management board & Supervisory board
CEO |
Daniel O’Day |
Management board |
Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Johanna Mercier, Cindy Perettie, Deborah H. Telman |
Supervisory board |
Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Kevin E. Lofton, Harish Manwani, Harish Manwani, Anthony Welters |
Company data
Name: |
Gilead Sciences Inc. |
Address: |
333 Lakeside Drive,Foster City, California 94404, USA |
Phone: |
+1-650-574-3000 |
Fax: |
+1-650-578-9264 |
E-mail: |
corporate_communicat...ead.com
corporate_communications@gilead.com
|
Internet: |
www.gilead.com |
Industry: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Sub sector: |
Pharmaceuticals |
End of financial year: |
12-31 |
Free Float: |
55.84% |
IPO date: |
1992-01-22 |
Company calendar
CW 32 | 2024-08-08
Interim Report 2nd Quarter/6 Months
|